News & Press Releases

Mintz is advising the placement agents in connection with the $350 million private placement that is expected to close immediately prior to the completion of the merger transaction between Obsidian Therapeutics, Inc. and Galera Therapeutics, Inc.

Mintz advised the placement agent in connection with ImageneBio’s $30 million private placement of pre-funded warrants.

Steven Shparber, Co-chair of Mintz’s Digital Infrastructure Practice, recently spoke with Data Center Knowledge about the growing use of behind-the-meter power by data center operators as they face grid delays and rising AI-driven demand.

Mintz advised the placement agent in connection with SCYNEXIS’ up to $92.2 million private placement. The private placement included upfront gross proceeds of approximately $40.0 million in common stock (or pre-funded warrants in lieu thereof) and accompanying common warrants, and up to an additional $52.2 million in gross proceeds if the common warrants are exercised for cash, subject to stockholder approval to increase the number of authorized shares of common stock.

David Adams was quoted in a CFO Dive article analyzing the challenges facing efforts to pass comprehensive federal AI legislation, and what the ongoing political gridlock and competing state-level approaches mean for businesses.

Of Counsel Michelle Capezza was quoted in a Business Insider article examining the push to expand private credit and other alternative investments into 401(k) retirement plans. The article discusses these developments in light of new regulations proposed by the Department of Labor, as well as ongoing questions about liquidity, valuation, and market volatility within the private credit space.